© 2001 by European Society of Cardiology
Copyright © 2001, European Society of Cardiology
Time course of arteriogenesis following femoral artery occlusion in the rabbit
aDepartment of Experimental Cardiology, Max-Planck-Institute for Physiological and Clinical Research, Benekestr. 2, D-61231 Bad Nauheim, Germany
bDepartments of Cardiology and Cardiovascular Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
* Corresponding author. Tel.: +49-6032-705-406; fax: +49-6032-705-419 ihoefer{at}kerckhoff.mpg.de
Objective: We examined the time course of arteriogenesis (collateral artery growth) after femoral artery ligation and the effect of monocyte chemoattractant protein-1 (MCP-1). Methods: New Zealand White rabbits received MCP-1 or phosphate buffered saline (PBS) for a 1-week period, either directly or 3 weeks after femoral artery ligation (non-ischemic model). A control group was studied with intact femoral arteries and another 1 min after acute femoral artery ligation. Results: Collateral conductance index significantly increased when MCP-1 treatment started directly after femoral artery ligation (acute occlusion: 0.94±0.19; without occlusion: 168.56±15.99; PBS: 4.10±0.48; MCP-1: 33.96±1.76 ml/min/100 mmHg). However, delayed onset of treatment 3 weeks after ligation and final study of conductance at 4 weeks showed no significant difference against a 4-week control (PBS: 79.08±7.24; MCP-1: 90.03±8.73 ml/min/100 mmHg). In these groups increased conductance indices were accompanied by a decrease in the number of visible collateral vessels (from 18 to 36 identifiable vessels at day 7 to about four at 21 days). Conclusion: We conclude that the chemokine MCP-1 markedly accelerated collateral artery growth but did not alter its final extent above that reached spontaneously as a function of time. We show thus for the first time that a narrow time window exists for the responsiveness to the arteriogenic actions of MCP-1, a feature that MCP-1 may share with other growth factors. We show furthermore that the spontaneous adaptation by arteriogenesis stops when only about 50% of the vasodilatory reserve of the arterial bed before occlusion are reached. The superiority of few large arterial collaterals in their ability to conduct large amounts of blood flow per unit of pressure as compared to the angiogenic response where large numbers of small vessels are produced with minimal ability to allow mass transport of bulk flow is stressed.
KEYWORDS Arteries; Blood flow; Collateral circulation; Macrophages; Microcirculation
1 Both authors contributed equally to this study.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S H Schirmer, F C van Nooijen, J J Piek, and N van Royen Stimulation of collateral artery growth: travelling further down the road to clinical application Heart, February 1, 2009; 95(3): 191 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. van Golde, M. S. Ruiter, N. C. Schaper, S. Voo, J. Waltenberger, W. H. Backes, M. J. Post, and M. S. Huijberts Impaired Collateral Recruitment and Outward Remodeling in Experimental Diabetes Diabetes, October 1, 2008; 57(10): 2818 - 2823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Sheridan, M. J. Ferguson, M. R. Distasi, F. A. Witzmann, M. C. Dalsing, S. J. Miller, and J. L. Unthank Impact of genetic background and aging on mesenteric collateral growth capacity in Fischer 344, Brown Norway, and Fischer 344 x Brown Norway hybrid rats Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3498 - H3505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Grundmann, N. van Royen, G. Pasterkamp, N. Gonzalez, E. J. Tijsma, J. J. Piek, and I. E. Hoefer A New Intra-Arterial DeliveryPlatform for Pro-Arteriogenic Compounds to Stimulate Collateral Artery Growth Via Transforming Growth Factor-{beta}1 Release J. Am. Coll. Cardiol., July 24, 2007; 50(4): 351 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Seidler, M. C. Lenter, B. D. Guth, and H. Doods Short-Term Intra-Arterial Infusion of Monocyte Chemoattractant Protein-1 Results in Sustained Collateral Artery Growth Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 61 - 68. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Fujii, Y. Yonemitsu, M. Onimaru, M. Tanii, T. Nakano, K. Egashira, T. Takehara, M. Inoue, M. Hasegawa, H. Kuwano, et al. Nonendothelial Mesenchymal Cell-Derived MCP-1 Is Required for FGF-2-Mediated Therapeutic Neovascularization: Critical Role of the Inflammatory/Arteriogenic Pathway Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2483 - 2489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. W. Zhuang, L. Gao, M. Murakami, J. D. Pearlman, T. J. Sackett, M. Simons, and E. D. de Muinck Arteriogenesis: Noninvasive Quantification with Multi-Detector Row CT Angiography and Three-dimensional Volume Rendering in Rodents Radiology, September 1, 2006; 240(3): 698 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Bergmann, I. E. Hoefer, B. Meder, H. Roth, N. van Royen, S. M. Breit, M. M. Jost, S. Aharinejad, S. Hartmann, and I. R. Buschmann Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice J. Leukoc. Biol., July 1, 2006; 80(1): 59 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Awad, E. I. Dedkov, C. Jiao, S. Bloomer, R. J. Tomanek, and G. C. Schatteman Differential Healing Activities of CD34+ and CD14+ Endothelial Cell Progenitors Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 758 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Michel, J.-S. Silvestre, L. Waeckel, S. Corda, T. Verbeuren, J. P. Vilaine, M. Clergue, M. Duriez, and B. I. Levy Thromboxane A2/Prostaglandin H2 Receptor Activation Mediates Angiotensin II-Induced Postischemic Neovascularization Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 488 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Helisch, S. Wagner, N. Khan, M. Drinane, S. Wolfram, M. Heil, T. Ziegelhoeffer, U. Brandt, J. D. Pearlman, H. M. Swartz, et al. Impact of Mouse Strain Differences in Innate Hindlimb Collateral Vasculature Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 520 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Grundmann, I. Hoefer, S. Ulusans, N. van Royen, S. H. Schirmer, C. K. Ozaki, C. Bode, J. J. Piek, and I. Buschmann Anti-tumor necrosis factor-{alpha} therapies attenuate adaptive arteriogenesis in the rabbit Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1497 - H1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. E. Hoefer, S. Grundmann, S. Schirmer, N. van Royen, B. Meder, C. Bode, J. J. Piek, and I. R. Buschmann Aspirin, But Not Clopidogrel, Reduces Collateral Conductance in a Rabbit Model of Femoral Artery Occlusion J. Am. Coll. Cardiol., September 20, 2005; 46(6): 994 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Leong-Poi, J. Christiansen, P. Heppner, C. W. Lewis, A. L. Klibanov, S. Kaul, and J. R. Lindner Assessment of Endogenous and Therapeutic Arteriogenesis by Contrast Ultrasound Molecular Imaging of Integrin Expression Circulation, June 21, 2005; 111(24): 3248 - 3254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Lloyd, B. M. Prior, H. Li, H. T. Yang, and R. L. Terjung VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H759 - H768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Prior, P. G. Lloyd, J. Ren, H. Li, H. T. Yang, M. H. Laughlin, and R. L. Terjung Time course of changes in collateral blood flow and isolated vessel size and gene expression after femoral artery occlusion in rats Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2434 - H2447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Song, P. S. Cottler, A. L. Klibanov, S. Kaul, and R. J. Price Microvascular remodeling and accelerated hyperemia blood flow restoration in arterially occluded skeletal muscle exposed to ultrasonic microbubble destruction Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2754 - H2761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hosaka, H. Koyama, T. Kushibiki, Y. Tabata, N. Nishiyama, T. Miyata, H. Shigematsu, T. Takato, and H. Nagawa Gelatin Hydrogel Microspheres Enable Pinpoint Delivery of Basic Fibroblast Growth Factor for the Development of Functional Collateral Vessels Circulation, November 23, 2004; 110(21): 3322 - 3328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Voskuil, I. E Hoefer, N. van Royen, J. Hua, S. de Graaf, C. Bode, I. R Buschmann, and J. J Piek Abnormal monocyte recruitment and collateral artery formation in monocyte chemoattractant protein-1 deficient mice Vascular Medicine, November 1, 2004; 9(4): 287 - 292. [Abstract] [PDF]
|
|
|
|
 |
|
 S. H. Schirmer, I. R. Buschmann, M. M. Jost, I. E. Hoefer, S. Grundmann, J.-P. Andert, S. Ulusans, C. Bode, J. J. Piek, and N. van Royen Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis Cardiovasc Res, November 1, 2004; 64(2): 356 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Heil and W. Schaper Influence of Mechanical, Cellular, and Molecular Factors on Collateral Artery Growth (Arteriogenesis) Circ. Res., September 3, 2004; 95(5): 449 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Pipp, S. Boehm, W.-J. Cai, F. Adili, B. Ziegler, G. Karanovic, R. Ritter, J. Balzer, C. Scheler, W. Schaper, et al. Elevated Fluid Shear Stress Enhances Postocclusive Collateral Artery Growth and Gene Expression in the Pig Hind Limb Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1664 - 1668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Niiyama, H. Kai, T. Yamamoto, T. Shimada, K.-I. Sasaki, T. Murohara, K. Egashira, and T. Imaizumi Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization J. Am. Coll. Cardiol., August 4, 2004; 44(3): 661 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. E. Hoefer, N. van Royen, J. E. Rectenwald, E. Deindl, J. Hua, M. Jost, S. Grundmann, M. Voskuil, C. K. Ozaki, J. J. Piek, et al. Arteriogenesis Proceeds via ICAM-1/Mac-1- Mediated Mechanisms Circ. Res., May 14, 2004; 94(9): 1179 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. van Royen, M. Voskuil, I. Hoefer, M. Jost, S. de Graaf, F. Hedwig, J.-P. Andert, T.A.M. Wormhoudt, J. Hua, S. Hartmann, et al. CD44 Regulates Arteriogenesis in Mice and Is Differentially Expressed in Patients With Poor and Good Collateralization Circulation, April 6, 2004; 109(13): 1647 - 1652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kondoh, H. Koyama, T. Miyata, T. Takato, H. Hamada, and H. Shigematsu Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor Cardiovasc Res, January 1, 2004; 61(1): 132 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Boengler, F. Pipp, B. Fernandez, T. Ziegelhoeffer, W. Schaper, and E. Deindl Arteriogenesis is associated with an induction of the cardiac ankyrin repeat protein (carp) Cardiovasc Res, September 1, 2003; 59(3): 573 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Srivastava, R. L. Terjung, and H. T. Yang Basic fibroblast growth factor increases collateral blood flow in spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1190 - H1197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. van Royen, J. J Piek, D. A Legemate, W. Schaper, J. Oskam, B. Atasever, M. Voskuil, D. Ubbink, S. H Schirmer, I. Buschmann, et al. Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial Vascular Medicine, August 1, 2003; 8(3): 191 - 196. [Abstract] [PDF]
|
|
|
|
|
|
K.-i. Sasaki, J. Duan, T. Murohara, H. Ikeda, S. Shintani, T. Shimada, T. Akita, K. Egami, and T. Imaizumi Rescue of hypercholesterolemia-related impairment of angiogenesis by oral folate supplementation J. Am. Coll. Cardiol., July 16, 2003; 42(2): 364 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Lloyd, B. M. Prior, H. T. Yang, and R. L. Terjung Angiogenic growth factor expression in rat skeletal muscle in response to exercise training Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1668 - H1678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Voskuil, N. van Royen, I. E. Hoefer, R. Seidler, B. D. Guth, C. Bode, W. Schaper, J. J. Piek, and I. R. Buschmann Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1 Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1422 - H1428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Deindl, I. E. Hoefer, B. Fernandez, M. Barancik, M. Heil, M. Strniskova, and W. Schaper Involvement of the Fibroblast Growth Factor System in Adaptive and Chemokine-Induced Arteriogenesis Circ. Res., March 21, 2003; 92(5): 561 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. van Royen, I. Hoefer, M. Bottinger, J. Hua, S. Grundmann, M. Voskuil, C. Bode, W. Schaper, I. Buschmann, and J.J. Piek Local Monocyte Chemoattractant Protein-1 Therapy Increases Collateral Artery Formation in Apolipoprotein E-Deficient Mice but Induces Systemic Monocytic CD11b Expression, Neointimal Formation, and Plaque Progression Circ. Res., February 7, 2003; 92(2): 218 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Heeschen, M. Weis, and J. P. Cooke Nicotine promotes arteriogenesis J. Am. Coll. Cardiol., February 5, 2003; 41(3): 489 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N van Royen, I Hoefer, I Buschmann, S Kostin, M Voskuil, C. Bode, W Schaper, and J.J Piek Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits Cardiovasc Res, January 1, 2003; 57(1): 178 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. F. Paoni, F. Peale, F. Wang, C. Errett-Baroncini, H. Steinmetz, K. Toy, W. Bai, P. M. Williams, S. Bunting, M. E. Gerritsen, et al. Time course of skeletal muscle repair and gene expression following acute hind limb ischemia in mice Physiol Genomics, December 3, 2002; 11(3): 263 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Sullivan, T. Doetschman, and J. B. Hoying Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb J Appl Physiol, December 1, 2002; 93(6): 2009 - 2017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Heil, T. Ziegelhoeffer, F. Pipp, S. Kostin, S. Martin, M. Clauss, and W. Schaper Blood monocyte concentration is critical for enhancement of collateral artery growth Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2411 - H2419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Horvath, J. Doukas, C.-Y. J. Lu, N. Belkind, R. Greene, G. F. Pierce, and D. A. Fullerton Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging Ann. Thorac. Surg., August 1, 2002; 74(2): 481 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. E. Hoefer, N. van Royen, J. E. Rectenwald, E. J. Bray, Z. Abouhamze, L. L. Moldawer, M. Voskuil, J. J. Piek, I. R. Buschmann, and C. K. Ozaki Direct Evidence for Tumor Necrosis Factor-{alpha} Signaling in Arteriogenesis Circulation, April 9, 2002; 105(14): 1639 - 1641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Lloyd, H. T. Yang, and R. L. Terjung Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2528 - H2538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Deindl, I. Buschmann, I. E. Hoefer, T. Podzuweit, K. Boengler, S. Vogel, N. van Royen, B. Fernandez, and W. Schaper Role of Ischemia and of Hypoxia-Inducible Genes in Arteriogenesis After Femoral Artery Occlusion in the Rabbit Circ. Res., October 26, 2001; 89(9): 779 - 786. [Abstract] [Full Text] [PDF]
|
|